Today's Trading
Day Low 538.77
Day High 555.00
Open:554.32
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Recently Viewed
More stories below advertisement
Latest
Description
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.Fundamentals
Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book
Earnings
Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Research
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
Moderate Buy
StockReports+
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
StockCalc
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
- PR Newswire - PRF - Mon Jan 25, 8:31AM CST
PR Newswire - PRF - CMTX
Mon Jan 25, 8:31AM CST
, /PRNewswire/ --Â InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN.
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
- PR Newswire - Mon Jan 25, 8:31AM CST
PR Newswire - PRNW
Mon Jan 25, 8:31AM CST
NEW YORK , Jan. 25, 2021 /PRNewswire/ --Â InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN.
Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021
- PR Newswire - Thu Jan 21, 11:01AM CST
PR Newswire - PRNW
Thu Jan 21, 11:01AM CST
TARRYTOWN, N.Y. and WASHINGTON , Jan. 21, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science  (the Society) today named 40 finalists in the Regeneron Science Talent Search 2021, the nation's oldest and most prestigious science and math competition for high school seniors.
Price History Describes more index sector components
Price Performance
Period | Period Low | Period High | Performance | |
---|---|---|---|---|
1-Month | 467.00 +15.74% increase on 01/06/21 | Period Open:488.93 | 554.84 -2.58% decrease on 01/25/21 | +51.58 (+10.55%) increase since 12/24/20 |
3-Month | 467.00 +15.74% increase on 01/06/21 | Period Open:579.81 | 596.80 -9.43% decrease on 11/05/20 | -39.30 (-6.78%) decrease since 10/23/20 |
52-Week | 328.13 +64.73% increase on 01/31/20 | Period Open:345.28 | 664.64 -18.68% decrease on 07/20/20 | +195.23 (+56.54%) increase since 01/24/20 |
More stories below advertisement